Literature DB >> 10378474

Effects of dietary vitamin E supplementation on pulmonary morphology and collagen deposition in amiodarone- and vehicle-treated hamsters.

J W Card1, R G Leeder, W J Racz, J F Brien, T M Bray, T E Massey.   

Abstract

Amiodarone (AM) is a potent antidysrhythmic agent that is limited in clinical use by its adverse effects, including potentially life-threatening AM-induced pulmonary toxicity (AIPT). The present study tested the ability of dietary supplementation with vitamin E (500 IU d,1-alpha-tocopherol acetate/kg chow) to protect against pulmonary damage following intratracheal administration of AM (1.83 micromol) to the male golden Syrian hamster. At 21 days post-dosing, animals treated with AM had increased lung hydroxyproline content and histological disease index values compared to control (P < 0.05), which were indicative of fibrosis. Dietary vitamin E supplementation for 6 weeks resulted in a 234% increase in lung vitamin E content at the time of AM dosing, and maintenance on the diet prevented AM-induced elevation of hydroxyproline content and disease index 21 days post-dosing. Dietary vitamin E supplementation also decreased hydroxyproline content and disease index values in hamsters treated intratracheally with distilled water, the AM vehicle. These results demonstrate a protective role for vitamin E in an in vivo model of AIPT, and suggest that this antioxidant may have non-specific antifibrotic effects in the lung.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10378474     DOI: 10.1016/s0300-483x(99)00009-8

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  8 in total

Review 1.  Amiodarone: review of pulmonary effects and toxicity.

Authors:  Spyros A Papiris; Christina Triantafillidou; Likurgos Kolilekas; Despoina Markoulaki; Effrosyni D Manali
Journal:  Drug Saf       Date:  2010-07-01       Impact factor: 5.606

Review 2.  Animal models of drug-induced pulmonary fibrosis: an overview of molecular mechanisms and characteristics.

Authors:  Shuchan Li; Jianrong Shi; Huifang Tang
Journal:  Cell Biol Toxicol       Date:  2021-11-05       Impact factor: 6.819

Review 3.  Antioxidants as potential therapeutics for lung fibrosis.

Authors:  Brian J Day
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

4.  Role of vitamin-E on rat liver-amiodarone: an ultrastructural study.

Authors:  Mohamed Samir A Zaki; Refaat A Eid
Journal:  Saudi J Gastroenterol       Date:  2009-04       Impact factor: 2.485

5.  Severe cholestatic jaundice in the elderly induced by low-dose amiodarone.

Authors:  Nimer Assy; G Khair; Sorina Schlesinger; Osamah Hussein
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.487

6.  Ultrastructural Changes in Rat's Atrial Cardiomyocytes After Short Term Administration of Amiodarone and Possible Protective Role of Vitamin E.

Authors:  Abdullah S Shatoor; Mohamed Samir Ahmad Zaki; Refaat A Eid; Mohamed A Sayed-Ahmad
Journal:  J Clin Med Res       Date:  2012-05-15

7.  Protective Effect of Caffeic Acid Phenethyl Ester (CAPE) on Amiodarone-Induced Pulmonary Fibrosisin Rat.

Authors:  Narjes Zaeemzadeh; Aliasghar Hemmati; Ardeshir Arzi; Mohammadtaha Jalali; Iran Rashidi
Journal:  Iran J Pharm Res       Date:  2011       Impact factor: 1.696

Review 8.  Insights into the Role of Bioactive Food Ingredients and the Microbiome in Idiopathic Pulmonary Fibrosis.

Authors:  Josep Mercader-Barceló; Joan Truyols-Vives; Carlos Río; Nora López-Safont; Ernest Sala-Llinàs; Alice Chaplin
Journal:  Int J Mol Sci       Date:  2020-08-22       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.